Compare Davita Inc (DVA) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Motorola Solutions Inc — how do they compare? Davita Inc trades at $232 (market cap $14.92B), while Motorola Solutions Inc trades at $421.22 (market cap $68.67B). The key difference: Motorola Solutions Inc is far larger — about 4.6× Davita Inc's market cap, and Motorola Solutions Inc pays a 1.17% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | MSI | |
|---|---|---|
Market Cap | $14.92B | $68.67B |
Sector | Health | Technology |
52-Week High | $235.71 | $490.30 |
52-Week Low | $103.87 | $363.83 |
Enterprise Value | $27.47B | $77.38B |
Dividend Yield | — | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
Motorola Solutions (MSI) trades at $418.06, down 1.14% today, with a neutral technical signal despite recent earnings beats. The company shows strong fundamentals with 2025 revenue of $11.68B and net income of $2.15B, supported by a 99.88% ROE. Recent developments include the $1.5B D-Fend acquisition and AI expansion for emergency response systems, positioning MSI for growth in public safety technology.
MSI presents a compelling investment case with analyst consensus price target of $512.33 (22.5% upside) and 71% buy ratings. Strong profitability and strategic AI investments are offset by high valuation multiples (P/E 33.71) and negative cash flow from significant acquisitions. Key risks include integration challenges from recent deals and competitive pressure in the public safety sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
